Biotechnology
/
Eastern Norway

Pronova Biopharma Norge AS
Omega-3-based pharmaceuticals

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenue: 1.156.181
    Operating profit: 169.641
    Operating profit before tax: 171.079
    Total assets: 886.163
    Total equity: 130.391
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Harald Pflanzl


    Board Members:
    Alexandra Bjerch-Andresen
    Hilde Nyheim
    Mark Walter Meier
    Thomas Reiersen
    Tor-Andre Andreassen
    Trygve Christophersen



    General Manager:
    Mark Walter Meier


    Subsidiary companies:
    Largest shareholders:
    N/A
    Animal or vegetable oils, Animal or vegetable oils and fats, Basic organic chemicals, Biotechnology, blood-forming organs and the cardiovascular system, chemical products and man-made fibres, Chemicals, Crude animal or vegetable oils and fats, Food products and beverages, Health Care, Medicinal products, Medicinal products for the alimentary tract and metabolism, Medicinal products for the blood, Vegetable oils,